Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as docetaxel and carboplatin, work in different
ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving docetaxel together with carboplatin
works in treating patients with ovarian epithelial, fallopian tube, or peritoneal cavity
cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center